Know Cancer

or
forgot password


Phase 1
1 Month
21 Years
Not Enrolling
Both
Liver Disease, Lymphoproliferative Disorders

Thank you

Trial Information

Inclusion Criteria


Pediatric patients s/p orthotopic liver transplantation

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Authority:

United States: Federal Government

Study ID:

PTLD (completed)

NCT ID:

NCT00063648

Start Date:

May 2002

Completion Date:

December 2007

Related Keywords:

  • Liver Disease
  • Lymphoproliferative Disorders
  • PTLD
  • CTL Therapy
  • Post-transplant lymphoproliferative disorder
  • Liver Diseases
  • Lymphoproliferative Disorders

Name

Location

Texas Children's HospitalHouston, Texas